Breaking silos in rare disease: How training drives cross-functional excellence
A field rep visits a treating specialist on a Tuesday. A field reimbursement manager (FRM) calls the same office on […]
Why pharma training needs a new playbook for rare disease
The rare disease sector is no longer a niche. Nearly half of all new drug approvals in the U.S. now address rare